Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0706649A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
UCB Pharma SA
Original Assignee
UCB Pharma SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by UCB Pharma SAfiledCriticalUCB Pharma SA
Priority to GB0706649ApriorityCriticalpatent/GB0706649D0/en
Publication of GB0706649D0publicationCriticalpatent/GB0706649D0/en
Priority to PCT/EP2008/002525prioritypatent/WO2008122378A1/en
Priority to US12/594,313prioritypatent/US20100168077A1/en
Priority to EP08734888Aprioritypatent/EP2144877A1/en
2,3-dihydro-pyrido-1,4-oxazine and 2,3-dihydro-4-oxa-1,9-diazaphenanthrene derivatives, processes for their preparation and pharmaceutical compositions comprising them
Substituted quinoline derivatives, pharmaceutical compositions, combinations and products comprising them, uses thereof and processes for their preparation